Let’s take a closer look. Imagine the Nifty is at 26,000 points or maybe at 22,000 points. Does it change how well a pharmaceutical company is doing after it just got approval from the US FDA for one of its factories? After four years of hard work, the answer is no, it doesn’t.
However, the Nifty’s points do matter when it comes to the stock price of that company. Even so, what truly counts for the stock price in the long run is how well the company is making money. Some people may say that other factors, like tariffs, can have an impact too, but at the end of the day, money is what matters most.
Leave a Reply